Saladax Extends Reach of My5-FU Test into Poland, Italy with Distribution Deals | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Saladax Biomedical today announced exclusive distribution deals for its My5-FU diagnostic test in Poland and Italy.

Saladax has appointed Genoxa of Puck, Poland to be its distributor of the test to oncologists in Poland, and AB Analitica of Padua, Italy to distribute the test to hospitals and reference laboratories in Italy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.